{"id":112665,"date":"2025-09-01T20:43:36","date_gmt":"2025-09-01T20:43:36","guid":{"rendered":"https:\/\/www.newsbeep.com\/ca\/112665\/"},"modified":"2025-09-01T20:43:36","modified_gmt":"2025-09-01T20:43:36","slug":"how-is-johnson-johnsons-stock-performance-compared-to-other-healthcare-stocks","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ca\/112665\/","title":{"rendered":"How Is Johnson &#038; Johnson\u2019s Stock Performance Compared to Other Healthcare Stocks?"},"content":{"rendered":"\n<p class=\"yf-1090901\">New Brunswick, New Jersey-based Johnson &amp; Johnson (JNJ) primarily focuses on drug discovery and manufacturing but has a diversified business model. With a market cap of\u00a0$425.8 billion, the company operates through\u00a0pharmaceuticals, medical devices, and consumer products divisions.<\/p>\n<p class=\"yf-1090901\">Companies worth $200 billion or more are generally described as &#8220;mega-cap stocks.&#8221; JNJ fits right into that category, with its market cap exceeding this threshold, reflecting its substantial size, influence, and dominance in the healthcare sector. The company\u2019s extensive operations span numerous countries spanning the Americas, EMEA, and the Indo-Pacific.<\/p>\n<\/p>\n<p class=\"yf-1090901\">Johnson &amp; Johnson touched its\u00a0three-year high of $181.16 on Aug. 22 and is currently trading 3.2% below that peak. Further, JNJ stock has\u00a0soared 15.1% over the past three months, notably outperforming the Health Care Select Sector SPDR Fund\u2019s (XLV)\u00a03.8% uptick during the same time frame.<\/p>\n<p>    <img fetchpriority=\"high\" decoding=\"async\" src=\"data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/ywAAAAAAQABAAACAUwAOw==\" alt=\"www.barchart.com\" loading=\"eager\" height=\"628\" width=\"960\" class=\"yf-1gfnohs loader\"\/> www.barchart.com      <\/p>\n<p class=\"yf-1090901\">Johnson &amp; Johnson has outperformed the healthcare sector over the long term as well. JNJ stock has gained 7% over the past 52 weeks and 21.3% on a YTD basis, compared to XLV\u2019s 12.4% plunge over the past year and marginal 83 bps dip in 2025.<\/p>\n<p class=\"yf-1090901\">To confirm the recent upturn, JNJ stock has jumped above its 200-day and 50-day moving averages in mid-July.<\/p>\n<p>    <img decoding=\"async\" src=\"data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/ywAAAAAAQABAAACAUwAOw==\" alt=\"www.barchart.com\" loading=\"lazy\" height=\"631\" width=\"960\" class=\"yf-1gfnohs loader\"\/> www.barchart.com      <\/p>\n<p class=\"yf-1090901\">Johnson &amp; Johnson\u2019s stock prices\u00a0surged 6.2% in a single trading session following the release of its\u00a0impressive Q2 results on Jul. 16. Driven by the strength and momentum of its strong product portfolio, the company\u2019s total revenues increased 5.8% year-over-year to $23.7 billion, beating the Street expectations by a notable 3.8%. Meanwhile, its adjusted EPS dipped 1.8% year-over-year to $2.77, but surpassed the consensus estimates by 4.1%, boosting investor confidence.<\/p>\n<p class=\"yf-1090901\">Moreover, Johnson &amp; Johnson has also outperformed its peer, AbbVie Inc.\u2019s (ABBV)\u00a06.4% gains over the past year and 17% surge in 2025.<\/p>\n<p class=\"yf-1090901\">JNJ stock has a consensus \u201cModerate Buy\u201d rating overall. As of writing, JNJ\u2019s mean price target of $177.36 represents a modest 1.1% upside potential. While the Street-high target of $200 suggests a notable 14% premium to current price levels.<\/p>\n<p class=\"yf-1090901\"> On the date of publication, Aditya Sarawgi did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally\u00a0published on <a href=\"https:\/\/www.barchart.com\/story\/news\/34471211\/how-is-johnson-johnsons-stock-performance-compared-to-other-healthcare-stocks?utm_source=yahoo&amp;utm_medium=syndication&amp;utm_content=footer_link\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Barchart.com;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">Barchart.com<\/a> <\/p>\n","protected":false},"excerpt":{"rendered":"New Brunswick, New Jersey-based Johnson &amp; Johnson (JNJ) primarily focuses on drug discovery and manufacturing but has a&hellip;\n","protected":false},"author":2,"featured_media":112666,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[49,48,84,392,63565,35363],"class_list":{"0":"post-112665","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-healthcare","8":"tag-ca","9":"tag-canada","10":"tag-health","11":"tag-healthcare","12":"tag-jnj-stock","13":"tag-johnson-johnson"},"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/112665","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/comments?post=112665"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/112665\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media\/112666"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media?parent=112665"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/categories?post=112665"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/tags?post=112665"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}